[12] In the same study, there were no significant differences for mRNA expression levels of AdipoR2 among control tissue, MT and adjacent healthy mammary tissues.[12] Higher adiponectin levels in breast tumors could be explained by the anti-inflammatory or protective effects of adiponectin against tumor development. The gene discussed is ADIPOR2; the disease is neoplasm.